Form 8-K - Current report:
SEC Accession No. 0001213900-24-084175
Filing Date
2024-10-02
Accepted
2024-10-01 18:01:06
Documents
18
Period of Report
2024-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0216237-8k_bionomic.htm   iXBRL 8-K 28521
2 SCHEME IMPLEMENTATION AGREEMENT, DATED OCTOBER 1, 2024, BETWEEN BIONOMICS LIMITE ea021623701ex2-1_bionomic.htm EX-2.1 367926
3 PRESS RELEASE, DATED OCTOBER 1, 2024, ISSUED BY BIONOMICS LIMITED ea021623701ex99-1_bionomic.htm EX-99.1 23727
4 GRAPHIC ex2-1_001.jpg GRAPHIC 5341
5 GRAPHIC ex2-1_002.jpg GRAPHIC 5040
6 GRAPHIC ex99-1_001.jpg GRAPHIC 6569
  Complete submission text file 0001213900-24-084175.txt   675894

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bnox-20241001.xsd EX-101.SCH 3027
8 XBRL LABEL FILE bnox-20241001_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE bnox-20241001_pre.xml EX-101.PRE 22367
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0216237-8k_bionomic_htm.xml XML 3655
Mailing Address 200 GREENHILL ROAD EASTWOOD SA C3 5063
Business Address 200 GREENHILL ROAD EASTWOOD SA C3 5063 61 8 8150 7400
BIONOMICS LIMITED/FI (Filer) CIK: 0001191070 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3
Type: 8-K | Act: 34 | File No.: 001-41157 | Film No.: 241344663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)